Various inhibitors were used to study the transport mechanisms of Aβ and its isoforms. The contribution of RAGE to the transport of Aβ across the endothelial monolayer was assessed using the antagonist of this receptor
FPS-ZM1 (Sigma) at a concentration of 20 μM (to obtain a stock solution,
FPS-ZM1 was dissolved in DMSO to a concentration of 305 mM). To study the caveolin-dependent transport of Aβ isoforms, the inhibitor
filipin (Sigma) was used at a concentration of 3 μg/ml (to obtain a stock solution,
filipin was dissolved in DMSO to a concentration of 5 mg/ml). An equivalent amount of DMSO was added to the control samples. The contribution of clathrin-dependent endocytosis was assessed using
chlorpromazine (Merck) at a concentration of 5 μg/ml (to obtain a stock solution,
chlorpromazine was dissolved in DMEM). These concentrations were selected based on literature data and tested for toxicity to bEnd.3 cells using MTT (
filipin) and WST (
FPS-ZM1 and
chlorpromazine) assays according to the manufacturer's protocol (
Supplementary Figure 2). Before experiments, cells were preincubated with inhibitors added to the upper transwell compartment for 1 h, after which they were filled with solutions containing the inhibitor and 1 μM Aβ, and samples were taken from the lower compartment after 2, 6 and 24 h.
Varshavskaya K.B., Petrushanko I.Y., Mitkevich V.A., Barykin E.P, & Makarov A.A. (2024). Post-translational modifications of beta-amyloid alter its transport in the blood-brain barrier in vitro model. Frontiers in Molecular Neuroscience, 17, 1362581.